| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) | 
|---|
| 02/27/1996 | CA1338089C Sulfonic acid esters | 
| 02/22/1996 | WO1996005220A1 Compounds for use in treatment of carcinomas | 
| 02/22/1996 | WO1996005219A1 Purified form of streptogramines, preparation thereof and pharmaceutical compositions containing it | 
| 02/22/1996 | WO1996005218A1 Delivery of nucleic acids | 
| 02/22/1996 | WO1996005160A1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents | 
| 02/22/1996 | DE4418691A1 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer 3 '- (4') non-radioactively labeled nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid-spacer | 
| 02/21/1996 | EP0474767B1 Dopamine agonists | 
| 02/20/1996 | US5492920 Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone | 
| 02/20/1996 | US5492916 Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone | 
| 02/20/1996 | US5492896 Pseudopeptides having an antiviral action | 
| 02/20/1996 | US5492895 Inhibitors of thrombosis | 
| 02/15/1996 | WO1996004403A1 Systematic evolution of ligands by exponential enrichment: chimeric selex | 
| 02/15/1996 | WO1996004298A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same | 
| 02/15/1996 | WO1996004242A1 Arylthio compounds as antibacterial and antiviral agents | 
| 02/15/1996 | WO1996004002A1 Remedy for corneal diseases | 
| 02/15/1996 | WO1996003987A1 Lactone compounds for treating patients with precancerous lesions | 
| 02/15/1996 | WO1996003982A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors | 
| 02/15/1996 | CA2196687A1 Corneal therapeutic agent | 
| 02/15/1996 | CA2196450A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same | 
| 02/15/1996 | CA2196183A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors | 
| 02/15/1996 | CA2193845A1 Arylthio compounds as antibacterial and antiviral agents | 
| 02/15/1996 | CA2172710A1 Lactone compounds for treating patients with precancerous lesions | 
| 02/14/1996 | EP0696593A2 Inhibitors of farnesyl protein transferase | 
| 02/14/1996 | EP0696318A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies | 
| 02/14/1996 | EP0696199A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes | 
| 02/14/1996 | CN1116847A N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists | 
| 02/14/1996 | CN1116628A Cyclopeptides of the formulal | 
| 02/14/1996 | CN1116627A New peptides derived from trifluorumethylketones, process for their preparation and the pharmaceutical compositions which contain them | 
| 02/13/1996 | US5491143 Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE | 
| 02/13/1996 | US5491132 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same | 
| 02/13/1996 | US5491074 Joining peptides by attaching association hexapeptide to each, mixing fusion complexes formed to dimerize association peptide | 
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA | 
| 02/12/1996 | CA2155448A1 Inhibitors of farnesyl protein transferase | 
| 02/09/1996 | CA2155496A1 Nucleic acid-binding oligomers for therapy and diagnosis | 
| 02/08/1996 | WO1996003428A1 Antiprotozoal cyclic tetrapeptides | 
| 02/08/1996 | WO1996003427A1 Peptide derived radionuclide chelators | 
| 02/08/1996 | WO1996003424A1 Combinatorial libraries of molecules and methods for producing same | 
| 02/08/1996 | WO1996003374A1 Thrombin inhibitors | 
| 02/08/1996 | CA2195089A1 Combinatorial libraries of molecules and methods for producing same | 
| 02/08/1996 | CA2194999A1 Antiprotozoal cyclic tetrapeptides | 
| 02/08/1996 | CA2194551A1 Peptide derived radionuclide chelators | 
| 02/08/1996 | CA2193844A1 Thrombin inhibitors | 
| 02/07/1996 | EP0695759A2 Human cancer inhibitory pentapeptide methyl esters | 
| 02/07/1996 | EP0695758A2 Human cancer inhibitory pentapeptide amides and esters | 
| 02/07/1996 | EP0695757A2 Human cancer inhibitory peptide amides | 
| 02/07/1996 | EP0695308A1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same | 
| 02/07/1996 | EP0695184A1 Hiv protease inhibitors | 
| 02/07/1996 | CN1030922C Process for preparation of new amino acid derivatives | 
| 02/06/1996 | US5489583 2-substituted 3-(4-amidinophenyl)propionic acid derivatives | 
| 02/02/1996 | CA2154206A1 Human cancer inhibitory pentapeptide amides and esters | 
| 02/02/1996 | CA2154205A1 Human cancer inhibitory peptide amides | 
| 02/02/1996 | CA2154203A1 Pentapeptide methyl esters | 
| 02/01/1996 | WO1996002564A1 Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process | 
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids | 
| 02/01/1996 | WO1996002552A1 Lung cancer marker | 
| 02/01/1996 | WO1996002549A1 SUBSTITUTED THIAZOLO[3,2-α]AZEPINE DERIVATIVE | 
| 02/01/1996 | WO1996002517A1 Substituted arylsulfonamides, their preparation and use as thrombin-inhibiting medicaments | 
| 02/01/1996 | WO1996002499A1 Difluorostatone antiviral agents | 
| 02/01/1996 | WO1996002267A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it | 
| 02/01/1996 | CA2195403A1 Lung cancer marker | 
| 01/31/1996 | EP0694041A1 A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING N-ALPHA-METHYLARGININE | 
| 01/31/1996 | EP0694040A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity | 
| 01/31/1996 | EP0694039A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity | 
| 01/31/1996 | EP0693941A1 Radiolabeled compounds for thrombus imaging | 
| 01/31/1996 | EP0593615B1 Aromatic compounds, compositions containing them and their use in therapy | 
| 01/31/1996 | EP0593557B1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy | 
| 01/30/1996 | US5488157 β-aminoalkyl and β-N-peptidylaminoalkyl boronic acids | 
| 01/30/1996 | US5488048 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace | 
| 01/30/1996 | US5488047 Hypotensive agents, analgesics; congestive heart failure | 
| 01/30/1996 | US5488037 Antithrombotic agents | 
| 01/30/1996 | CA1338015C Process for industrially synthesizing 2(2s, 3as, 7as) perhydroindole-2-carboxylic acid | 
| 01/25/1996 | WO1996001841A1 Cationic lipids for delivery of nucleic acids to cells | 
| 01/25/1996 | WO1996001840A1 Cationic lipids for delivery of nucleic acids to cells | 
| 01/25/1996 | WO1996001655A1 Cascade-polymer complexes and methods of producing the same | 
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases | 
| 01/25/1996 | WO1996001645A1 Use of muramyl peptide compounds | 
| 01/25/1996 | WO1996001644A1 Inhibitors of leukocyte adhesion | 
| 01/25/1996 | CA2194678A1 Use of muramyl peptide compounds | 
| 01/25/1996 | CA2194560A1 Cascade-polymer complexes and methods of producing the same | 
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases | 
| 01/25/1996 | CA2193508A1 Inhibitors of leukocyte adhesion | 
| 01/24/1996 | EP0693129A1 Method of inhibiting the transcription of genes | 
| 01/24/1996 | EP0693083A1 Alpha-ketoamide derivatives as inhibitors of thrombosis | 
| 01/24/1996 | EP0693082A1 Immuno modulated peptide derivatives of leukokinin fragments | 
| 01/24/1996 | EP0693081A1 Cyclic compounds and compositions which inhibit bone resorption | 
| 01/24/1996 | EP0693064A1 Hydrophobic aminocoumarin derivatives and their use as proteolytic enzyme substrates or in the preparation of such substrates | 
| 01/24/1996 | EP0692982A1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS | 
| 01/24/1996 | EP0692979A1 Bifunctional chelators and their use in radiopharmaceuticals | 
| 01/24/1996 | EP0692968A1 Urokinase plasminogen activator fragments | 
| 01/24/1996 | EP0692931A1 Synthetic matrix metalloprotease inhibitors and uses thereof | 
| 01/23/1996 | US5486529 Certain pyridyl ketones for treating diseases involving leukocyte elastase | 
| 01/23/1996 | US5486513 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors or enkephalinase and ace | 
| 01/23/1996 | US5486466 Enzyme inhibitors | 
| 01/18/1996 | DE4424828A1 Neue substituierte Arylsulfonamide, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted aryl sulfonamides, their preparation and their use as medicaments | 
| 01/17/1996 | EP0691987A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa | 
| 01/17/1996 | EP0691986A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS | 
| 01/17/1996 | EP0691985A1 Phosphonomethyldipeptides | 
| 01/17/1996 | EP0493480B1 Dehydrodidemnin b | 
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion | 
| 01/17/1996 | CN1030703C Neurokinin A antagonists |